Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131586) titled 'Clinical Study on the Safety of Xian Yimoucao Capsule for Postpartum Women' on Sept. 4.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Beijing University of Chinese Medicine Dongzhimen Hospital Luoyang Branch
Condition:
AI Postpartum lochia
Intervention:
Study group: treated with Fresh Motherwort Capsule:None
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-04-24
Target Sample Size: Study group: treated with Fresh Motherwort Capsule:300;Control group: without Fresh Motherwort Capsule treatment:100;
Countries of Recruitment:
China
To know more, ...